Reshma Kewalramani Salary and Compensation - VERTEX PHARMACEUTICALS INC / MA CEO Pay 2024
In fiscal year 2024, Reshma Kewalramani, CEO and President of VERTEX PHARMACEUTICALS INC / MA (VRTX), received total compensation of $21.5 million.
Reshma Kewalramani's compensation breakdown includes: base salary of $1.5 million, stock awards valued at $15.0 million, and other compensation of $4.9 million.
Compared to fiscal year 2023, Reshma Kewalramani's total compensation increased 4% from $20.6 million to $21.5 million.
VERTEX PHARMACEUTICALS INC / MA (VRTX) Executive Pay 2024
VERTEX PHARMACEUTICALS INC / MA's top 4 named executive officers received combined total compensation of $44.3 million in fiscal year 2024.
The named executive officers disclosed in VERTEX PHARMACEUTICALS INC / MA's 2024 proxy statement are:Reshma Kewalramani (CEO and President) with total compensation of $21.5 million, Charles F. Wagner (EVP & Chief Financial Officer) with total compensation of $7.9 million, David M. Altshuler () with total compensation of $7.6 million, and Nia Tatsis () with total compensation of $7.3 million.